Serina Therapeutics SER
NYSE SER
$2.00 -0.01 (-0.48%)
As of: Oct 1, 2026 · 3:14 PM EDT

Serina Therapeutics (SER) Total Debt (2020 - 2025)

Updated

Serina Therapeutics' Total Debt was $2.89 million in Q3 2025, down 74.1% from $11.16 million a year earlier.

Analysis

Serina Therapeutics (SER) Total Debt (2020 - 2025) Analysis & Trends

At the end of FY2022, Total Debt at Serina Therapeutics came in at $18.12 million, up 37.3% from FY2021.

  • In earlier years, Total Debt was $13.2 million in FY2021 and $436,000 in FY2020.
  • The Q3 2025 figure marks the lowest quarterly Total Debt since Q3 2023.
  • Compared with a year earlier, Total Debt was higher in 1 of the last four quarters, with growth averaging 49.3%.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 49.04 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 70.82 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 53.91 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 37.49 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -111.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 57.30 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 26.25 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 63.19 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Serina Therapeutics 32.93 Mn -7.81 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 2.89 Mn
Sep 30, 2024 11.16 Mn
Jun 30, 2024 11.14 Mn
Mar 31, 2024 10.44 Mn
Sep 30, 2023 2.22 Mn
Jun 30, 2023 33.01 Mn
Mar 31, 2023 30.05 Mn
Dec 31, 2022 18.12 Mn
Sep 30, 2022 15.65 Mn
Dec 31, 2021 13.20 Mn
Dec 31, 2020 436,000.00
Sep 30, 2020 4.94 Mn
API Access

Serina Therapeutics Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=SER&period=max&api_key=YOUR_API_KEY